The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information, the reported additional therapy/non-surgical treatment and treatment with medications were due to case circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that the procedure was to treat the right distal superficial femoral artery (sfa)/proximal popliteal occlusion.A 6.0x40mm absolute pro self-expanding stent was advanced and deployed; however, due to the support wire being inserted into the wrong vessel 1mm of the distal end of the stent was placed in the collateral vessel.It was attempted to retrieve/reposition the stent through balloon manipulation but was not possible.The stent wall was blocking the desired guide wire path.Due to this, the physician was unable to pass a wire through the stent struts as the femoral artery/popliteal was occluded (target lesion) at this section as well, making crossing the lesion more challenging.The collateral vessel remained patent and it was decided to treat the patient with medical management with the option to bypass at a later time.No adverse patient effect or clinically significant delay was reported.No additional information was provided.
|